Last reviewed · How we verify

Glucocorticoid (GC)

First Affiliated Hospital of Zhejiang University · FDA-approved active Small molecule

Glucocorticoid (GC) is a Glucocorticoid Small molecule drug developed by First Affiliated Hospital of Zhejiang University. It is currently FDA-approved for Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis), Allergic and asthmatic conditions, Adrenal insufficiency. Also known as: Prednisone.

Glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene transcription.

Glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene transcription. Used for Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis), Allergic and asthmatic conditions, Adrenal insufficiency.

At a glance

Generic nameGlucocorticoid (GC)
Also known asPrednisone
SponsorFirst Affiliated Hospital of Zhejiang University
Drug classGlucocorticoid
TargetGlucocorticoid receptor (GR)
ModalitySmall molecule
Therapeutic areaImmunology, Rheumatology, Endocrinology
PhaseFDA-approved

Mechanism of action

Glucocorticoids are steroid hormones that bind to intracellular glucocorticoid receptors, translocate to the nucleus, and alter transcription of pro-inflammatory genes. This results in decreased production of cytokines, chemokines, and adhesion molecules, leading to broad immunosuppression and anti-inflammatory effects across multiple cell types including T cells, B cells, macrophages, and neutrophils.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Glucocorticoid (GC)

What is Glucocorticoid (GC)?

Glucocorticoid (GC) is a Glucocorticoid drug developed by First Affiliated Hospital of Zhejiang University, indicated for Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis), Allergic and asthmatic conditions, Adrenal insufficiency.

How does Glucocorticoid (GC) work?

Glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene transcription.

What is Glucocorticoid (GC) used for?

Glucocorticoid (GC) is indicated for Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis), Allergic and asthmatic conditions, Adrenal insufficiency, Hematologic malignancies and lymphomas.

Who makes Glucocorticoid (GC)?

Glucocorticoid (GC) is developed and marketed by First Affiliated Hospital of Zhejiang University (see full First Affiliated Hospital of Zhejiang University pipeline at /company/first-affiliated-hospital-of-zhejiang-university).

Is Glucocorticoid (GC) also known as anything else?

Glucocorticoid (GC) is also known as Prednisone.

What drug class is Glucocorticoid (GC) in?

Glucocorticoid (GC) belongs to the Glucocorticoid class. See all Glucocorticoid drugs at /class/glucocorticoid.

What development phase is Glucocorticoid (GC) in?

Glucocorticoid (GC) is FDA-approved (marketed).

What are the side effects of Glucocorticoid (GC)?

Common side effects of Glucocorticoid (GC) include Hyperglycemia, Hypertension, Osteoporosis, Immunosuppression/increased infection risk, Cushingoid features, Mood disturbances.

What does Glucocorticoid (GC) target?

Glucocorticoid (GC) targets Glucocorticoid receptor (GR) and is a Glucocorticoid.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing